{"id":31772,"date":"2024-03-08T16:27:02","date_gmt":"2024-03-08T15:27:02","guid":{"rendered":"https:\/\/carpem.fr\/?p=31772"},"modified":"2024-03-08T16:27:02","modified_gmt":"2024-03-08T15:27:02","slug":"valerie-taly-ranked-among-the-palmares-des-inventeurs-2024-for-methys-dx","status":"publish","type":"post","link":"https:\/\/carpem.fr\/en\/valerie-taly-ranked-among-the-palmares-des-inventeurs-2024-for-methys-dx\/","title":{"rendered":"Val\u00e9rie Taly ranked among the \u201cpalmar\u00e8s des inventeurs\u201d 2024 for METHYS Dx"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text]The 2024 inventors’ prize list<\/a>, initiated by the French magazine Le Point, has been published. An exceptional jury selected “the 100 leading teams whose research will change our lives<\/strong>“, including Val\u00e9rie Taly for the start-up METHYS Dx<\/strong>, in the biotech category. The awards ceremony took place at the Paris-Saclay Summit on March 1.<\/p>\n

This distinction rewards the efforts of the entire METHYS Dx team, which is developing an innovative diagnostic solution for monitoring cancer patients, using a simple blood test (liquid biopsy) to assess the effectiveness of treatments and detect recurrences. Created in 2021 with the support of SATT Erganeo, the start-up capitalizes on over a decade of collaborative work by the MEPPOT (CARPEM team 1 at the Cordeliers Research Center) and SPM (molecular system and programming, Gulliver Laboratory, ESPCI) teams, with the support of their institutions (AP-HP, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Universit\u00e9 PSL, Inserm and the CNRS).[\/vc_column_text]